STEPSTONE GROUP LP
Q2 2026 Form 13-F
LA JOLLA, CALIFORNIA
CIK 0001502287
· CRD 143635
· SEC-registered investment adviser
$2.2B Reported Value Total
STEPSTONE GROUP LP reports 412 total accounts under management (AUM). There are 365 discretionary accounts valued at $95,348,232,878, and 47 non-discretionary accounts valued at $12,476,195,548.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
509 funds
· $126.5B gross asset value
Private Equity Fund: $117.7B · Venture Capital Fund: $8.8B · Real Estate Fund: $4.7M · Hedge Fund: $236
Source: Form ADV filed 2026-07-30
Reported value
$2.2B
Quarter over quarter
+20.6%
Holdings
23
Top-10 concentration
99.2%
Key People
Form ADV owners & control persons
Bendukai Edward Bouey
CHIEF COMPLIANCE OFFICER
Jose Agustin Fernandez
CO-CHIEF OPERATING OFFICER, PARTNER
Scott William Hart
PARTNER, CHIEF EXECUTIVE OFFICER
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q2 2026 13F record
Q2 2026 13F filing summary
| Period of report | June 30, 2026 |
|---|---|
| Filed | August 13, 2026 |
| Form | 13F-HR |
| Reported value | $2.2B |
| Positions | 23 |
| Change in reported value | +940.2% |
| New positions | 9 |
| Exited positions | 4 |
| Position turnover | 48.2% |
| Top-10 concentration | 99.2% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 13, 2026
|
23 | $2.2B |
|
Q1 2026 13F
Filed May 15, 2026
|
18 | $207.5M |
|
Q4 2025 13F
Filed Feb 17, 2026
|
23 | $186.9M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
16 | $212.7M |
|
Q2 2025 13F
Filed Aug 13, 2025
|
14 | $50.4M |
|
Q1 2025 13F
Filed May 14, 2025
|
16 | $97.4M |
|
Q4 2024 13F
Filed Feb 13, 2025
|
14 | $114.4M |
|
Q3 2024 13F
Filed Nov 12, 2024
|
14 | $274.1M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
16 | $493.1M |
|
Q1 2024 13F
Filed May 13, 2024
|
21 | $471.6M |
|
Q4 2023 13F
Filed Feb 13, 2024
|
22 | $555.6M |
|
Q3 2023 13F
Filed Nov 13, 2023
|
22 | $448.9M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
24 | $540.8M |
|
Q1 2023 13F
Filed May 15, 2023
|
21 | $538.1M |
|
Q4 2022 13F
Filed Feb 10, 2023
|
24 | $766.5M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
30 | $703.1M |
|
Q2 2022 13F
Filed Aug 12, 2022
|
27 | $934.9M |
|
Q1 2022 13F
Filed May 13, 2022
|
22 | $1.3B |
|
Q4 2021 13F
Filed Feb 11, 2022
|
37 | $1.8B |
|
Q3 2021 13F
Filed Nov 12, 2021
|
23 | $1.5B |
33 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q2 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | SPCX SPACE EXPLORATION TECHN CORP | $1.9B | 86.62% |
| 2 | STUB STUBHUB HLDGS INC | $97.3M | 4.51% |
| 3 | CBRS CEREBRAS SYSTEMS INC | $75.2M | 3.48% |
| 4 | XNDU XANADU QUANTUM TECHNOLO LTD | $41.4M | 1.92% |
| 5 | TMS TEAMSHARES INC | $16.4M | 0.76% |
| 6 | OKUR ONKURE THERAPEUTICS INC | $12.1M | 0.56% |
| 7 | KRMN KARMAN HLDGS INC | $12.0M | 0.56% |
| 8 | KDK KODIAK AI INC | $7.2M | 0.33% |
| 9 | TRDA ENTRADA THERAPEUTICS INC | $5.6M | 0.26% |
| 10 | EIKN EIKON THERAPEUTICS INC | $5.2M | 0.24% |
| 11 | PHAT PHATHOM PHARMACEUTICALS INC. | $4.6M | 0.21% |
| 12 | CHYM CHIME FINL INC | $3.1M | 0.14% |
| 13 | KLAR KLARNA GROUP PLC | $2.7M | 0.12% |
| 14 | DDOG DATADOG INC | $1.8M | 0.09% |
| 15 | NAVN NAVAN INC | $1.3M | 0.06% |
| 16 | GENVR GEN DIGITAL INC | $788.0K | 0.04% |
| 17 | CRWD CROWDSTRIKE HLDGS INC | $748.3K | 0.03% |
| 18 | GROV GROVE COLLABORATIVE HOLD INC | $476.2K | 0.02% |
| 19 | TNYA TENAYA THERAPEUTICS INC | $341.5K | 0.02% |
| 20 | VIA VIA TRANSN INC | $290.3K | 0.01% |
Values as reported on the Q2 2026 Form 13F. Every position is in the holdings table below.